research Oral Minoxidil for Chemotherapy-Induced Alopecia
Oral minoxidil may effectively treat hair loss from chemotherapy.
Search
for
Sort by
Research
990-1000 / 1000+ results 
research Comparative study between the Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in the Treatment of Male Androgenic Alopecia
Minoxidil is the most common treatment for male hair loss, but sildenafil shows promise as an alternative.
research Strontium Ranelate Promotes Chondrogenesis Through Inhibition of the Wnt/β-catenin Pathway
Strontium ranelate helps cartilage growth by blocking a specific cell pathway.
research Molybdenum Nanoparticles as a Potential Topical Medication for Alopecia Treatment Through Antioxidant Pathways that Differ from Minoxidil
Nano-sized molybdenum may help treat hair loss and works well with minoxidil.
research Clinical effects of microneedling at different depths combined with external minoxidil tincture on male androgenetic alopecia
0.5 mm microneedling with minoxidil effectively and safely treats male hair loss.
research Referee report. For: Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study [version 1; referees: 2 approved]
Oral minoxidil significantly reduces hair shedding in women with chronic telogen effluvium.
research Topical minoxidil for nail growth: A conventional medication with a novel indication
Minoxidil, a hair loss treatment, may help nails grow faster.
research Preparation and evaluation of a multimodal minoxidil microemulsion versus minoxidil alone in the treatment of androgenic alopecia of mixed etiology: a pilot study
The multimodal microemulsion with minoxidil, diclofenac, and tea tree oil is more effective for hair growth than minoxidil alone.
research Minoxidil Beyond Hair: A Comprehensive Review of Its Effects on Nail Growth
Minoxidil may help nails grow faster and stronger.
research Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.